PharmaVoice ٢٦ مارس ٢٠٢٦ How former Acorda CEO Ron Cohen landed at a Parkinson’s cell therapy startup
PharmaVoice ١٦ مارس ٢٠٢٦ 340B: When the safest move can feel like no move at all. Why “waiting” is no longer a viable strategy
PharmaVoice ١٠ مارس ٢٠٢٦ Executives want in, but researchers want out — how pharma’s US job picture is changing